Persephone

Founded by two PhDs, Persephone is on a mission to set the standard of care for the human gut microbiome. The immune system is imprinted in the first two years of life and it starts in the gut. But in the largest infant microbiome study ever conducted in the US by Persephone, more than 75% of infants lacked the necessary populations of bacteria that are scientifically indicated to build our internal blueprint for vitality and longevity. 9 out of 10 infants lacked a key gut microbe essential for immune development. By identifying the most resilient and beneficial strains in their dataset and pairing them with HMOs (the essential sugars found in breast milk that these microbes need to flourish) Persephone has developed first-of-their-kind synergistic synbiotics for infants and toddlers. These synbiotics mark a breakthrough in pediatric gut health, laying the microbial foundation for a stronger immune system and a longer, healthier life.